Armistice Capital

Armistice Capital is a global, long/short, value-oriented and event-driven hedge fund focused primarily on the health care and consumer sectors. We invest predominantly in equities and can be opportunistic across the capital structure. We seek to maximize the opportunity set of investment candidates allowing for the selection of unique, concentrated bets to generate uncorrelated returns. We maintain significant position and portfolio level hedges in an effort to mitigate basis and market risks. We view our strategy as the marriage of value and event and aim to produce compelling risk-adjusted returns in all markets.

Steven Boyd, Chief Investment Officer, founded Armistice Capital in 2012. Steven was the first analyst at Senator Investment Group in 2008, joining the firm with its founders from York Capital.

Armistice was the winner of 2017 US Hedge Fund Performance Awards by HFM for long/short equity, long/short equity long-term performance (5 years) under $1bn, and single manager long-term performance under $1bn.*